Corilagin ameliorates atherosclerosis by regulating MMP-1, -2, and -9 expression in vitro and in vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Corilagin ameliorates atherosclerosis by regulating MMP-1, -2, and -9 expression in vitro and in vivo

Published:2021-09 Issue: Volume:906 Page:174200
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Tao Yiting,Zhang Li,Yang Renhua,Yang Yongzhao,Jin Haonan,Zhang Xiaochao,Hu Qin,He Bo,Shen Zhiqiang,Chen Peng

Funder

Natural Science Foundation of Yunnan Province

Yunnan Province

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology

Reference42 articles.

1. Primary prevention of atherosclerosis by pretreatment of low-density lipoprotein receptor knockout mice with sesame oil and its aqueous components;Aluganti Narasimhulu;Sci. Rep.,2018

2. Apoptotic and genomic effects of corilagin on SKOV3 ovarian cancer cell line;Attar;OncoTargets Ther.,2017

3. Major vault protein suppresses obesity and atherosclerosis through inhibiting IKK-NF-κB signaling mediated inflammation;Ben;Nat. Commun.,2019

4. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion;Brand;J. Clin. Invest.,1996

5. NF-κB directs dynamic super enhancer formation in inflammation and atherogenesis;Brown;Mol. Cell.,2014

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glycoprotein non-metastatic melanoma protein B (GPNMB): An attractive target in atherosclerosis;Biochemical and Biophysical Research Communications;2024-11

2. Astrocyte-Derived MMP-9 is a Key Mediator of PRV Penetration of the Blood-Brain Barrier and Tight Junction Disruption;2024-09-03

3. (-)-Epicatechin gallate prevented atherosclerosis by reducing abnormal proliferation of VSMCs and oxidative stress of AML 12 cells;Cellular Signalling;2024-09

4. Protective Effect of Corilagin on Alcoholic Liver Injury;Natural Product Communications;2024-09

5. MEK inhibitors: a promising targeted therapy for cardiovascular disease;Frontiers in Cardiovascular Medicine;2024-07-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3